PortfoliosLab logo
LifeMD, Inc. (LFMD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US53216B1044

CUSIP

53216B104

IPO Date

Jan 2, 2001

Highlights

Market Cap

$522.19M

EPS (TTM)

-$0.33

Total Revenue (TTM)

$220.89M

Gross Profit (TTM)

$203.16M

EBITDA (TTM)

$2.62M

Year Range

$3.99 - $12.31

Target Price

$12.63

Short %

10.30%

Short Ratio

1.63

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


LifeMD, Inc.

Performance

Performance Chart


Loading data...

S&P 500

Returns By Period

LifeMD, Inc. (LFMD) returned 146.67% year-to-date (YTD) and 43.65% over the past 12 months. Over the past 10 years, LFMD delivered an annualized return of 37.65%, outperforming the S&P 500 benchmark at 10.85%.


LFMD

YTD

146.67%

1M

65.90%

6M

85.28%

1Y

43.65%

3Y*

75.73%

5Y*

53.13%

10Y*

37.65%

^GSPC (Benchmark)

YTD

0.51%

1M

6.15%

6M

-2.00%

1Y

12.92%

3Y*

12.68%

5Y*

14.19%

10Y*

10.85%

*Annualized

Monthly Returns

The table below presents the monthly returns of LFMD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202512.53%-5.57%3.42%35.29%65.90%146.67%
2024-32.57%42.40%29.15%16.05%-30.85%-16.85%3.94%-26.93%0.58%-22.14%61.52%-24.89%-40.29%
20232.06%-10.10%-4.49%-2.35%17.47%123.08%8.97%-18.57%61.92%0.16%23.00%7.66%327.32%
2022-5.68%1.92%-5.11%-36.83%0.90%-9.33%21.57%3.63%-23.35%11.17%10.96%-20.16%-49.87%
2021218.84%5.38%-27.89%-38.62%32.65%-8.54%-16.72%-19.67%-21.19%-19.65%-18.44%-4.91%-40.74%
202016.67%-7.14%61.54%28.57%7.41%3.45%213.33%43.62%22.22%-27.39%48.58%-26.63%988.33%
201921.43%-17.65%7.14%20.00%-22.22%-21.43%27.27%-7.14%30.77%-0.00%0.00%-29.41%-14.29%
2018-17.65%-3.57%3.70%-0.00%-17.86%-4.35%9.09%16.67%-28.57%-0.00%0.00%-30.00%-58.82%
2017-7.69%16.67%78.57%-14.00%-16.28%-16.67%40.00%-11.90%16.22%-0.00%-9.30%-12.82%30.77%
201625.00%66.67%20.00%-20.00%20.83%-10.34%-0.00%-7.69%8.33%3.85%7.41%-10.34%116.67%
201580.00%-5.56%5.88%-22.22%-28.57%-10.00%44.44%-15.38%-54.55%160.00%-46.15%71.43%20.00%
20143.85%-7.41%0.00%-24.00%-21.05%-6.67%-14.29%-8.33%18.18%-15.38%27.27%-28.57%-61.54%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of LFMD is 73, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of LFMD is 7373
Overall Rank
The Sharpe Ratio Rank of LFMD is 6767
Sharpe Ratio Rank
The Sortino Ratio Rank of LFMD is 7777
Sortino Ratio Rank
The Omega Ratio Rank of LFMD is 7575
Omega Ratio Rank
The Calmar Ratio Rank of LFMD is 7676
Calmar Ratio Rank
The Martin Ratio Rank of LFMD is 7070
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for LifeMD, Inc. (LFMD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

LifeMD, Inc. Sharpe ratios as of May 31, 2025 (values are recalculated daily):

  • 1-Year: 0.45
  • 5-Year: 0.50
  • 10-Year: 0.27
  • All Time: 0.13

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of LifeMD, Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History


LifeMD, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the LifeMD, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the LifeMD, Inc. was 96.24%, occurring on Mar 17, 2023. The portfolio has not yet recovered.

The current LifeMD, Inc. drawdown is 60.03%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.24%Feb 18, 2021524Mar 17, 2023
-87.8%Dec 10, 2013455Sep 30, 2015358Mar 3, 2017813
-87.34%Mar 7, 2017580Jun 25, 2019263Jul 10, 2020843
-81.05%Aug 4, 2003366Dec 29, 200553May 3, 2006419
-81.03%May 8, 2006204Oct 1, 200739Jan 29, 2008243
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of LifeMD, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of LifeMD, Inc., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -79.9%.


-2.50-2.00-1.50-1.00-0.500.0020212022202320242025
0.03
0.14
Actual
Estimate

Valuation

The Valuation section provides an overview of how LifeMD, Inc. is priced in the market compared to other companies in the Pharmaceutical Retailers industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for LFMD relative to other companies in the Pharmaceutical Retailers industry. Currently, LFMD has a P/S ratio of 2.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for LFMD in comparison with other companies in the Pharmaceutical Retailers industry. Currently, LFMD has a P/B value of 107.7. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items